Vertex Pharmaceuticals Non-GAAP EPS of $3.05 beats by $0.05, revenue of $2.37B beats by $30M
Vertex Pharmaceuticals press release  (NASDAQ:VRTX): Q1  Non-GAAP EPS of $3.05  beats by $0.05.
Revenue of $2.37B (+12.9% Y/Y)  beats by $30M.
Â Company reiterates full year 2023 financial guidance, including product revenue guidance of $9.55 to $9.7 billionÂ vs. $9.73B consensus